Trial Profile
A Phase I, Randomized, Placebo-Controlled, Crossover Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs SRT 2104 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- Sponsors Sirtris
- 06 Jan 2012 Actual end date changed from Apr 2010 to May 2010 as reported by ClinicalTrials.gov.
- 28 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jan 2011 Planned end date changed from 1 Feb 2011 to 1 Oct 2011 as reported by ClinicalTrials.